CompletedNCT02854943

Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis

Studying Acquired hemophagocytic lymphohistiocytosis associated with malignant disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Gunnar Lachmann
Principal Investigator
Gunnar Lachmann, MD
Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Operative Intensive Care Medicine
Enrollment
2623 enrolled
Eligibility
18 years · All sexes
Timeline
20002018

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02854943 on ClinicalTrials.gov

Other trials for Acquired hemophagocytic lymphohistiocytosis associated with malignant disease

Additional recruiting or active studies for the same condition.

See all trials for Acquired hemophagocytic lymphohistiocytosis associated with malignant disease

← Back to all trials